基于aptamer的自组装纳米细胞使有效和有针对性的药物输送成为可能
Ganghui Chen1,2, Dongsheng Mao1, Xuan Wang1
1Institute of Molecular Medicine (IMM), Shanghai Jiao Tong University School of Medicine, Renji Hospital, College of Chemistry and Chemical Engineering, Shanghai Jiao Tong University, Shanghai, 200240, China.
Journal of nanobiotechnology
|November 10, 2023
概括
研究人员为癌症治疗开发了超稳定的核酸胺基. 这种新的纳米输送系统增强了药物向和有效性,提供了更安全,更有效的癌症治疗解决方案.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 癌症纳米医学 癌症纳米医学
背景情况:
- 基于核酸体的纳米细胞显示出纳米医学的前景.
- 现有的阿普坦米在生理环境中缺乏稳定性,阻碍了癌细胞的向.
- 这种不稳定性损害了癌症治疗的有效性.
研究的目的:
- 为增强癌症治疗开发一个超稳定的细胞纳米输送系统.
- 为了解决两性阿帕特马菌的固有不稳定性.
- 创建一个通用平台,用于加载用于癌症治疗的疏水性药物.
主要方法:
- 一种两性共聚合物的自组合,聚乙烯-化--1-八二烯 (C18PMH),与核酸聚体.
- 利用Ce6作为评估瘤向和细胞吸收的模型药物.
- 在癌症模型中评估药物载菌体的治疗效果.
主要成果:
- 开发的C18-aptamer小粒体在生理环境中表现出超稳定性.
- 观察到有效的瘤向和结合能力.
- 通过光动力学疗法成功地进入了模型药物 (Ce6) 的细胞.
- 微粒显示出有效地装载和输送其他疏水性药物的潜力.
结论:
- 这种C18-aptamer小粒体代表了癌症治疗纳米输送系统的重大进步.
- 增强的稳定性和向性提高了药物输送效率和治疗结果.
- 该平台提供了一种通用且更安全的方法,通过多种药物输送来治疗各种癌症.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


